Belgian Annual Report on Drugs:
New developments, trends and in-depth information
Seperate chapters:
TDI
The treatment demand indicator related to drugs and alcohol in 2011-2014 in Brussels [FR] and Wallonia [FR]
VAD [NL]
Eurotox [FR]
EMCDDA reports [EN]
UNODC reports [EN]
WHO reports [EN]
|
|
Identification of a new tert-leucinate class synthetic cannabinoid in powder and "spice-like" herbal incenses: 5F-MDMB-PICA
A case of acute intoxication due to combined use of fentanyl and U-47700
Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol
General practice patients treated for substance use problems. A cross-national surveillance study
Non-general practice versus general practice patients treated for substance use problems
Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium)
Symposium Methods in Epidemiology 17/09/2015, Leuven-Belgium
Hepatitis V virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention
PLoS One 2014 vol.9 no.7 e103345
4-methyl-amphetamine: a health threat for recreational amphetamine users
Journal of psychopharmacology 2013 vol.27 no.9 817-822
Improved Benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10
Archives of public health 2013 vol.71 no.
|
|
An integrated drug policy in Belgium
Joined Declaration by the Interministerial Drug Conference 2010 [FR] - [NL]
Belgian Monitoring Centre for Drugs and Drug Addiction (BMCDDA)
European drug policy documents
|